Sharing my favorite article by my favorite persons Inas Abuali, MD and Fawzi Abu Rous, MD , 2 years on, still valid, still true!

connection.asco.org/blogs/what-wou…

The future of #lungcancer is bright with these #3MusketeersforLCSM Eric K. Singhi, MD Aakash Desai, MD, MPH & Fawzi Abu Rous, MD
It has been such a privilege to work with you boys!
#TTLC24 #LCSM

Soaking in some quality time with my fellow #3MusketeersforLCSM and the one and only Jill Feldman!

Moving the field forward with #patienteducation research is our passion! #TTLC24 #lcsm

Aakash Desai, MD, MPH Fawzi Abu Rous, MD Jill Feldman IASLC LUNGevity Foundation

Do you have questions for Scott Gettinger, Jeremy Cetnar, Dara Aisne, Bruce Johnson, Fawzi Abu Rous, MD, Narjust Florez, MD, FASCO, or Dr. Luis E. Raez? Come participate in our panel now at #TTLC24 . #IASLC

Team LungCancerRx 🫁💊 representing at #TTLC24 !

What’s your favorite moment of the conference so far? Eric K. Singhi, MD Aakash Desai, MD, MPH Fawzi Abu Rous, MD Stephen V Liu, MD Narjust Florez, MD, FASCO Charu Aggarwal, MD, MPH, FASCO Lecia Sequist, MD, MPH Dr. Estela Rodriguez Balazs Halmos IASLC

My dad, transplant nephrologist Dr El-khatib, whose family was expelled from Haifa in 1948, ended up in Jenin Refugee camps and eventually in Jordan, has been an American citizen and practicing physician serving communities since the 90’s. Marching in DC for freedom yesterday.

Since we wrote this letter to The Lancet the stats resulting from attacks by #IOF on HCW and faculties have doubled. ~130 HCW killed, 57 facilities targeted resulting in 12 hospitals and 32 facilities being non-operational .1
#NotATarget #MedTwitter

thelancet.com/journals/lance…

#Thankful to be a moderator at #DCLung23 ! I appreciated the #METworking nod from Balazs Halmos and am grateful for the opportunity from Dr. Stephen V Liu, MD. #lcsm MedStar Georgetown Georgetown Hematology/Oncology Fellowship Hem-Onc Fellows Network

👐 الجود

الحمدلله
I was presented the opportunity to have my first oral presentation about Hot Topics in Basic and Translational Science that’ll be held in Brussels Belgium 🇧🇪

Im so honored and thankful especially to my brother and friend Hassan Abushukair and Dr. Fawzi Abu Rous, MD.

Really honored to talk about #SoMe in #oncology at the 4th Athenian Oncology Congress #4AOC !
Vivek Subbiah, MD Sanjay Popat Jessica Menis Alfredo Addeo MD Christophe Massard Jill Feldman
Personally, and professionally #SoMe has been a great journey! 🙏 Giannis Mountzios for invitation! UAB Medicine

Today, we are hosting the first Hematology/ Oncology research retreat. Looking forward to learn what great research our fellows are doing!
Henry Ford Health #OncTwitter

Lots of great participation, everyone!

As the patient is asymptomatic, the correct answer is to first obtain tissue biopsy to:

1) confirm no transformation of histology
2) evaluate for a potential acquired mechanism of resistance to target

#lcsm #meded

CheckMate 77T - phase 3 trial of neoadj chemo-nivolumab followed by adjuvant nivolumab is pos for event-free survival. Results may help delineate contribution of adjuvant PD-1 blockade after neoadjuvant chemo-PD1 when looked at in context of CM816. #lcsm news.bms.com/news/corporate…

Real world outcomes with lurbinectedin for #SCLC (n=90) in Clinical Lung Cancer from Dr. Aakash Desai, MD, MPH et al. In 2L (n=50), mPFS 2.1m (4.6m in platinum sensitive with 90d definition) and mOS 5.1m (7.8m in platinum sensitive).

clinical-lung-cancer.com/article/S1525-…

🚨Out in Clinical Lung Cancer our 📄 on “RWD with Lurbinectedin in 2L and beyond for ES-SCLC” #lcsm
➡️ Modest efficacy: mOS 5.1-5.6 months, mPFS 2.1-3.4 months.
➡️ neutropenia, anemia, fatigue, No severe toxicities 🚫
🙏 We need to do more for #SCLC Mayo Clinic Hematology-Oncology Fellowship UAB Medicine OncoAlert